Collegium Pharmaceutical, Inc.

8-K/A FORM 8-K/A Jun 30, 2026 8-K Shareholder vote results May 15, 2026 8-K Completed an acquisition or disposition; Director or officer change; Regulation FD disclosure May 12, 2026 10-Q Quarter ended 2026-03-31 May 7, 2026 8-K Results of operations (earnings release); Regulation FD disclosure May 7, 2026 8-K Director or officer change Apr 7, 2026 8-K Entered a material agreement; Regulation FD disclosure Mar 19, 2026 10-K Fiscal year ended 2025-12-31 Feb 26, 2026 8-K Results of operations (earnings release); Regulation FD disclosure Feb 26, 2026 8-K Regulation FD disclosure Jan 8, 2026 8-K Entered a material agreement; Terminated a material agreement; Unregistered sale of equity; Regulation FD disclosure Dec 30, 2025 10-Q Quarter ended 2025-09-30 Nov 6, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Nov 6, 2025 10-Q Quarter ended 2025-06-30 Aug 7, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Aug 7, 2025 8-K Other events Jul 7, 2025 8-K Director or officer change; Shareholder vote results May 19, 2025 8-K Other events May 12, 2025 10-Q Quarter ended 2025-03-31 May 8, 2025 8-K Results of operations (earnings release); Regulation FD disclosure May 8, 2025 8-K Director or officer change; Other events Mar 17, 2025 10-K Fiscal year ended 2024-12-31 Feb 27, 2025 8-K Results of operations (earnings release); Director or officer change; Regulation FD disclosure Feb 27, 2025 8-K Director or officer change Feb 5, 2025 8-K Regulation FD disclosure Jan 8, 2025 8-K/A FORM 8-K/A Nov 14, 2024 10-Q Quarter ended 2024-09-30 Nov 7, 2024 8-K Results of operations (earnings release); Director or officer change; Regulation FD disclosure Nov 7, 2024 8-K Completed an acquisition or disposition; Took on a direct financial obligation; Regulation FD disclosure Sep 4, 2024 10-Q Quarter ended 2024-06-30 Aug 8, 2024 8-K Results of operations (earnings release); Regulation FD disclosure Aug 8, 2024 8-K Entered a material agreement; Results of operations (earnings release); Took on a direct financial obligation; Director or officer change; Regulation FD disclosure Jul 29, 2024 8-K Other events Jun 13, 2024 8-K Director or officer change May 24, 2024 8-K Shareholder vote results May 20, 2024 8-K Other events May 13, 2024 8-K Director or officer change May 10, 2024 10-Q Quarter ended 2024-03-31 May 9, 2024 8-K Results of operations (earnings release); Regulation FD disclosure May 9, 2024 8-K Entered a material agreement Apr 29, 2024